Skip Header

1 - 25 of 57 results for author:"Benson M.D." in Literature citations

Page of 3 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (33)

Ephrin-B stimulation of calvarial bone formation.

Benson M.D., Opperman L.A., Westerlund J., Fernandez C.R., San Miguel S., Henkemeyer M., Chenaux G.

Dev. Dyn. 241:1901-1910(2012) · Mapped (20)

Palmitoylated TMX and calnexin target to the mitochondria-associated membrane.

Lynes E.M., Bui M., Yap M.C., Benson M.D., Schneider B., Ellgaard L., Berthiaume L.G., Simmen T.

EMBO J. 31:457-470(2012) · Mapped (11)

Ephrin reverse signaling controls palate fusion via a PI3 kinase-dependent mechanism.

San Miguel S., Serrano M.J., Sachar A., Henkemeyer M., Svoboda K.K., Benson M.D.

Dev. Dyn. 240:357-364(2011) · Mapped (12)

Progression of transthyretin amyloid neuropathy after liver transplantation.

Liepnieks J.J., Zhang L.Q., Benson M.D.

Neurology 75:324-327(2010) · Mapped (6)

Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation.

Liepnieks J.J., Benson M.D.

Amyloid 14:277-282(2007) · Mapped (6)

Rab-GTPase-dependent endocytic recycling of Kv1.5 in atrial myocytes.

McEwen D.P., Schumacher S.M., Li Q., Benson M.D., Iniguez-Lluhi J.A., Van Genderen K.M., Martens J.R.

J. Biol. Chem. 282:29612-29620(2007) · Mapped (1)

Genetic microheterogeneity of human transthyretin detected by IEF.

Altland K., Benson M.D., Costello C.E., Ferlini A., Hazenberg B.P.C., Hund E., Kristen A.V., Linke R.P., Merlini G., Salvi F. et al.

Electrophoresis 28:2053-2064(2007) · UniProtKB (1) · Mapped (5)

SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5.

Benson M.D., Li Q.J., Kieckhafer K., Dudek D., Whorton M.R., Sunahara R.K., Iniguez-Lluhi J.A., Martens J.R.

Proc. Natl. Acad. Sci. U.S.A. 104:1805-1810(2007) · UniProtKB (1)

ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae.

Elefteriou F., Benson M.D., Sowa H., Starbuck M., Liu X., Ron D., Parada L.F., Karsenty G.

Cell Metab. 4:441-451(2006) · Mapped (54)

Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis.

Liepnieks J.J., Wilson D.L., Benson M.D.

Amyloid 13:170-177(2006) · Mapped (6)

Inflammation-responsive transcription factor SAF-1 activity is linked to the development of amyloid A amyloidosis.

Ray A., Shakya A., Kumar D., Benson M.D., Ray B.K.

J. Immunol. 177:2601-2609(2006) · Mapped (9)

Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth.

Benson M.D., Romero M.I., Lush M.E., Lu Q.R., Henkemeyer M., Parada L.F.

Proc. Natl. Acad. Sci. U.S.A. 102:10694-10699(2005) · Mapped (11)

A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population.

Yamashita T., Hamidi Asl K., Yazaki M., Benson M.D.

Amyloid 12:127-130(2005) · Mapped (6)

Analysis of cDNA sequences of feline SAAs.

van Rossum M., van Asten F.J., Rofina J., Lenstra J.A., Benson M.D., Gruys E.

Amyloid 11:38-43(2004) · UniProtKB (15)

NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos.

Kuorilehto T., Nissinen M., Koivunen J., Benson M.D., Peltonen J.

J. Bone Miner. Res. 19:983-989(2004) · Mapped (14)

Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene.

Vidal R., Ghetti B., Takao M., Brefel-Courbon C., Uro-Coste E., Glazier B.S., Siani V., Benson M.D., Calvas P., Miravalle L. et al.

J. Neuropathol. Exp. Neurol. 63:363-380(2004) · UniProtKB (1) · Mapped (6)

Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid.

Yazaki M., Liepnieks J.J., Kincaid J.C., Benson M.D.

Muscle Nerve 28:438-442(2003) · Mapped (6)

Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His.

Blevins G., Macaulay R., Harder S., Fladeland D., Yamashita T., Yazaki M., Hamidi Asl K., Benson M.D., Donat J.R.

Neurology 60:1625-1630(2003) · UniProtKB (1)

An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians.

Yamada T., Okuda Y., Takasugi K., Wang L., Marks D., Benson M.D., Kluve-Beckerman B.

Amyloid 10:7-11(2003) · Mapped (3)

A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis.

Yazaki M., Farrell S.A., Benson M.D.

Kidney Int. 63:1652-1657(2003) · Mapped (4)

A new transthyretin variant Leu55Gln in a patient with systemic amyloidosis.

Yazaki M., Varga J., Dyck P.J., Benson M.D.

Amyloid 9:268-271(2002) · UniProtKB (1)

A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.

Subramanian L., Benson M.D., Iniguez-Lluhi J.A.

J. Biol. Chem. 278:9134-9141(2003) · UniProtKB (1) · Mapped (8)

Rapidly progressive amyloid polyneuropathy associated with a novel variant transthyretin serine 25.

Yazaki M., Yamashita T., Kincaid J.C., Scott J.R., Auger R.G., Dyck P.J., Benson M.D.

Muscle Nerve 25:244-250(2002) · Mapped (6)

Biochemical characterization of a neuroserpin variant associated with hereditary dementia.

Yazaki M., Liepnieks J.J., Murrell J.R., Takao M., Guenther B., Piccardo P., Farlow M.R., Ghetti B., Benson M.D.

Am. J. Pathol. 158:227-233(2001) · Mapped (3)

A novel variant of transthyretin (Glu89Lys) associated with familial amyloidotic polyneuropathy.

Nakamura M., Hamidi Asl K., Benson M.D.

Amyloid 7:46-50(2000) · UniProtKB (1)

to top of page·

Page of 3 | Next »